pillbase.ru

Ablymico

Active substance: liraglutide

liraglutide

Centralised EU authorisationActive

Marketing holder: STADA Arzneimittel AG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 20
  • LIRAGLUTIDE
    INJECTION, SOLUTION · LIRAGLUTIDE 6 mg/mL
    81607-018
    Orbicular Pharmaceutical Technologies Private Limited
  • LIRAGLUTIDE
    INJECTION, SOLUTION · LIRAGLUTIDE 6 mg/mL
    69097-920
    Cipla USA Inc.
  • Liraglutide
    INJECTION, SOLUTION · LIRAGLUTIDE 18 mg/3mL
    14403-3400
    Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
  • Liraglutide
    INJECTION, SOLUTION · LIRAGLUTIDE 6 mg/mL
    70377-095
    Biocon Pharma Inc.
  • Liraglutide
    INJECTION · LIRAGLUTIDE 6 mg/mL
    50090-7501
    A-S Medication Solutions
All products in this country (20)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-490f-733b-8f13-cff36ad82dd1,01a1208c-b4a6-7152-a279-97efbfdd972e,01a1208c-d9b9-783f-8736-6ab8a3753c69,01a1208d-2e11-7e9c-a959-70e29965ecbb,01a1208d-ad9c-79e1-bc37-ecf88a2eb4a7;count=19 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006620
Registration status
Active
ATC code
A10BJ02
Sources
  • product · EMA · EMEA/H/C/006620 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006620 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006620 · Verified 2026-10-09